Henry Schein 2026 Q3: Global Dental Distribution merchandise sales of $1.295 billion, up 7.0% year-over-year

Source: Henry Schein Q3 2026 Financial Results Report

2026 Q3 single-quarter net sales of USD 3.471 billion / Net profit attributable to shareholders of the parent company of USD 119 million / Global Dental Distribution segment Q3 sales up 7.0% year over year

DENTALGOODNEWS (Leading Dental Industry Media, DGN) | Henry Schein, Inc. (Nasdaq: HSIC) released its third-quarter financial results on November 3, 2026. The report shows that the company's third-quarter single-quarter net sales were USD 3.471 billion (approximately RMB 23.308 billion), up 4.0% year over year; net profit attributable to shareholders of the parent company calculated under Generally Accepted Accounting Principles (GAAP) was USD 119 million (approximately RMB 799 million), up approximately 17.8% year over year based on the rounded amounts disclosed in the financial report.

For the first three quarters of 2026, Henry Schein's cumulative net sales were USD 10.297 billion (approximately RMB 69.144 billion), up 5.6% year over year; cumulative GAAP net profit attributable to shareholders of the parent company was USD 320 million (approximately RMB 2.149 billion), up approximately 7.7% from USD 297 million (approximately RMB 1.994 billion) in the same period last year, based on the rounded amounts disclosed in the financial report.

Source: Henry Schein Q3 2026 Financial Results Report

By business segment, Global Distribution and Value-Added Services third-quarter sales were USD 2.944 billion (approximately RMB 19.769 billion), up 3.7% year over year; first three quarters were USD 8.694 billion (approximately RMB 58.380 billion), up 5.4% year over year. Among them, Global Dental Distribution merchandise third-quarter sales were USD 1.295 billion (approximately RMB 8.696 billion), up 7.0% year over year; first three quarters were USD 3.924 billion (approximately RMB 26.350 billion), up 8.6% year over year. Dental distribution equipment third-quarter sales were USD 449 million (approximately RMB 3.015 billion), up 2.3% year over year; first three quarters were USD 1.322 billion (approximately RMB 8.877 billion), up 4.7% year over year.

Global Medical Distribution third-quarter sales were USD 1.138 billion (approximately RMB 7.642 billion), up 1.1% year over year; first three quarters were USD 3.268 billion (approximately RMB 21.945 billion), up 2.2% year over year. Global Value-Added Services third-quarter sales were USD 62 million (approximately RMB 416 million), down 4.8% year over year; first three quarters were USD 180 million (approximately RMB 1.209 billion), up 3.1% year over year. Global Specialty Products third-quarter sales were USD 391 million (approximately RMB 2.626 billion), up 6.1% year over year; first three quarters were USD 1.207 billion (approximately RMB 8.105 billion), up 7.6% year over year. Global Technology business third-quarter sales were USD 181 million (approximately RMB 1.215 billion), up 5.2% year over year; first three quarters were USD 535 million (approximately RMB 3.593 billion), up 6.8% year over year.

Source: Henry Schein Q3 2026 Financial Results Report

On profitability, third-quarter net profit attributable to shareholders of the parent company calculated under Generally Accepted Accounting Principles (GAAP) was USD 119 million (approximately RMB 799 million), and Diluted EPS (Earnings Per Share) was USD 1.06 (approximately RMB 7.12), up 26.2% year over year; non-GAAP net profit attributable to shareholders of the parent company was USD 175 million (approximately RMB 1.175 billion), and Diluted EPS (Earnings Per Share) was USD 1.56 (approximately RMB 10.48), up 13.0% year over year.

In the quarter, net tariff refund gains contributed USD 0.19 per share (approximately RMB 1.28), while revaluation gains in the same period last year contributed USD 0.23 per share (approximately RMB 1.54). Excluding these two items, non-GAAP Diluted EPS (Earnings Per Share) was USD 1.37 (approximately RMB 9.20), compared with USD 1.15 (approximately RMB 7.72) in the same period last year, up 19.1% year over year. Third-quarter Adjusted EBITDA was USD 321 million (approximately RMB 2.156 billion); the Adjusted EBITDA margin was 9.24%, up 40 basis points year over year.

Source: Henry Schein Q3 2026 Financial Results Report

The company raised its 2026 non-GAAP Diluted EPS (Earnings Per Share) guidance to USD 5.50 to 5.56 (approximately RMB 36.93 to 37.34) from the previous USD 5.29 to 5.39 (approximately RMB 35.52 to 36.19), maintained its full-year sales growth guidance at 4.5% to 5.5%, and expects Adjusted EBITDA to achieve high-single-digit growth. The company said the raised guidance takes into account the third-quarter net tariff refund gains, limited and targeted growth investments in the fourth quarter, and improved operating performance, and assumes no further significant tariff refunds or revaluation gains during the year.

Henry Schein stated in 2025 that its value-creation initiatives are expected to deliver more than USD 200 million (approximately RMB 1.343 billion) in Operating Profit improvement over the coming years. Management reiterated this target on the Q3 financial earnings call and expects to reach an annualized Operating Profit improvement run rate of USD 125 million (approximately RMB 839 million) by the end of 2026.